Alvotech to present at upcoming investor conferences in September

Rhea-AI Summary

Alvotech (NASDAQ: ALVO; ALVO-SDB) announced that Founder and Chairman Robert Wessman and Chief Strategy Officer Dr. Balaji V. Prasad will take part in two New York investor events in September 2026: a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 at 12:20 pm ET (16:20 GMT), and investor meetings at Deutsche Bank's 2026 Healthcare Summit on September 17.

A live webcast of the Morgan Stanley fireside chat will be available via the Investors section of Alvotech's website, with a replay accessible for 90 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REYKJAVIK, ICELAND (August 27, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Robert Wessman, Founder and Chairman, and Dr. Balaji V. Prasad, Chief Strategy Officer, will participate in the upcoming investor conferences in September as follows:

• Morgan Stanley 24^th Annual Global Healthcare Conference in New York – Fireside chat on Tuesday, September 15, 2026 at 12:20 pm ET (16:20 GMT)
• Deutsche Bank's 2026 Healthcare Summit in New York – Hosting investor meetings on Thursday, September 17, 2026.

A live webcast of the fireside chat will be available to the general public and can be accessed in the Investors Section of Alvotech's website under Events and Presentations. After the event, a recording will be available for replay for 90 days.

For further information, contact:

Media
Benedikt Stefansson
Sarah MacLeod
alvotech.media@alvotech.com

Investors
Dr. Balaji V Prasad
Benedikt Stefansson
Mikaela Vilchez
alvotech.ir@alvotech.com

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® (golimumab), Eylea® (aflibercept) and Prolia®/Xgeva® (denosumab). The current development pipeline includes disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. For more information, please visit https://www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

For more information, please visit our  website or follow us on social media on LinkedIn, Facebook, Instagram, and YouTube.

FAQ

When will Alvotech (NASDAQ: ALVO) present at the Morgan Stanley 24th Annual Global Healthcare Conference in 2026?

Alvotech will participate in a fireside chat on September 15, 2026 at 12:20 pm ET (16:20 GMT). According to Alvotech, the session is part of the Morgan Stanley 24th Annual Global Healthcare Conference in New York.

How can investors watch Alvotech's September 15, 2026 Morgan Stanley fireside chat webcast (ALVO)?

Investors can watch the live webcast in the Investors section of Alvotech's website under Events and Presentations. According to Alvotech, a recording of the fireside chat will be available for replay for 90 days after the event.

What is Alvotech's schedule at Deutsche Bank's 2026 Healthcare Summit in New York?

Alvotech will host investor meetings on Thursday, September 17, 2026 at Deutsche Bank's 2026 Healthcare Summit in New York. According to Alvotech, Founder and Chairman Robert Wessman and Chief Strategy Officer Dr. Balaji V. Prasad will participate.

Who from Alvotech (ALVO) will represent the company at the September 2026 investor conferences?

Alvotech will be represented by Robert Wessman, Founder and Chairman, and Dr. Balaji V. Prasad, Chief Strategy Officer. According to Alvotech, they will join both the Morgan Stanley conference and Deutsche Bank's Healthcare Summit.

Will a replay of Alvotech's September 15, 2026 investor fireside chat be available for shareholders?

Yes, a replay of the fireside chat will be available for 90 days after the event. According to Alvotech, shareholders can access this recording via the Investors section of the company’s website under Events and Presentations.